Home > Insider Trading > Verona Pharma Plc

Verona Pharma Plc (VRNA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
21 - 28

Is Verona Pharma plc (VRNA) A Good Stock To Buy?

Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...

Keep Reading →

October 4th, 2021 - Hedge Funds News

10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman

In this article, we will discuss the 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.

Keep Reading →

July 6th, 2021 - Hedge Funds News

Is VRNA A Good Stock To Buy Now?

In this article we will check out the progression of hedge fund sentiment towards Verona Pharma plc (NASDAQ:VRNA) and determine whether it is a good investment right now.

Keep Reading →

December 11th, 2020 - Hedge Funds News

25 Best U.S. Cities to Live With Asthma

Navigating through life with asthma can be a life-long challenge in itself. Sometimes it becomes very important to constantly monitor your surroundings to detect any triggers.

Keep Reading →

November 24th, 2020 - Lists News

Is Verona Pharma plc (VRNA) A Good Stock To Buy?

With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...

Keep Reading →

November 28th, 2019 - Hedge Funds News

Market Movers Today: Biohaven Pharmaceutical Holding Co Ltd (BHVN), Facebook, Inc. (FB), Longfin Corp (LFIN), Verona Pharma PLC - ADR (VRNA), and More

Biohaven Pharmaceutical Holding Co. Ltd.

Keep Reading →

March 26th, 2018 - Market Movers News

13D Filing: OrbiMed Advisors and Verona Pharma PLC (VRNA)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...

Keep Reading →

May 8th, 2017 - Hedge Funds

13G Filing: Foresite Capital Fund III, L.P. and Verona Pharma PLC (VRNA)

SOLE VOTING POWER5,000,000 ordinary shares (“shares”) represented by 625,000 American Depositary Shares (“ADSs”), except that Foresite Capital Management III, LLC (“FCM III”), the general ...

Keep Reading →

May 5th, 2017 - Hedge Funds